medigraphic.com
ISSN 0210-5187 (Digital)

2005, Número 2

<< Anterior Siguiente >>

Med Cutan Iber Lat Am 2005; 33 (2)


Enfermedad de Hailey-Hailey y modalidades terapéuticas

Sánchez MP, Pérez J, Lázaro AC, Pilar GM, Carapeto FJ

Idioma: Español
Referencias bibliográficas: 43
Paginas: 83-90
Archivo PDF: 372.49 Kb.


RESUMEN

Este artículo ofrece una amplia revisión de los aspectos etiopatogénicos y clínicos del pénfigo benigno familiar, incidiendo especialmente en las diferentes modalidades terapéuticas ensayadas con mayor o menor éxito. Modalidades de tratamiento: tópico (corticoesteroides, antifúngicos, antibióticos, tacalcitol, ciclosporina, tacrolimus); sistémico: (corticoesteroides, vitamina E, vitamina D, talidomida, dapsona, retinoides, ciclosporina, metotrexato); quirúrgico: (dermabrasión, lásers, PUVA, radioterapia superficial, terapia fotodinámica); excisión-injerto y toxina botulínica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ikeda S, Welsh EA, Peluso AM, Leyden W, Duvic M, Woodley DT, et al. Localization of the gene whose mutations underlie Hailey-Hailey disease to chromosome 3q. Hum Mol Genet 1994;3:1147-50.

  2. Sakuntabhai A, Ruiz-Pérez V, Carter S, Jacobsen N, Burge S, Smith M, et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nature Genet 1999;21:271-7.

  3. Hu Z, Bonifas JM, Beech J, Bench G, Shigihara T, Ogawa H, et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nature Genet 2000;24:61-5.

  4. Sudbrak R, Brown J, Dobson-Stone C, CarterS, Ramser S, White J, et al. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca2+ pump. Hum Mol Genet 2000;9:1131-40.

  5. Li H, Sun XK, Zhu XJ. Four novel mutations in ATP2C1 found in Chinese patients with Hailey-Hailey disease. Br J Dermatol 2003;149:471-4.

  6. Ganor S, Sagher F. Keratosis follicularis (Darier) and familial benign chronic pemphigus(Hailey-Hailey) in the same patient. Br J Dermatol 1965;77:24-29.

  7. Cram DL, Muller SA, Winkelmann RK. Ultraviolet induced acantholysis in familial benign chronic pemphigus. Arch Dermatol 1967;96:636-41.

  8. Loewenthal LJA. Familial benign chronic pemphigus. The role of pyogenic bacteria. Arch Dermatol 1959;80:318-26.

  9. Schluepen EM, Wollenberg A, Haenel S, Stumpenhausen G, Volkenandt M, et al. Detection of herpes simplex virus in exacerbated pemphigus vulgaris by polymerase chain reaction. Dermatology 1996;192:312-6.

  10. Izumi AK, Shmunes E, Wood MG. Familial benign chronic pemphigus. The role of trauma including contact sensitivity. Arch Dermatol 1971;104:177-81.

  11. Burge S. Hailey-Hailey disease: the clinical features response to treatment and prognosis. Br J Dermatol 1992;126:275-82.

  12. García I, De la Torre C, Losada A, Ocampo C, Cruces MJ. Enfermedad de Hailey-Hailey con afectación extensa de la piel, cuero cabelludo y uñas. Actas Dermosifiliogr 1998;89:489-91.

  13. Marsch WC, Stüttgen G. Generalized Hailey-Hailey disease. Br J Dermatol 1978;99:553-60.

  14. Mejía P, Palou J. Acantólisis. Piel 2000;15: 137-41.

  15. Weedon D. Skin pathology. China: Churchill Livingstone, 2002;298-9.

  16. Shigaku I, Yasushi S, Hideoki O. Successful management of Hailey-Hailey disease with potent topical steroid ointment. J Dermatol Sci 1993;5:205-11.

  17. Aoki T, Hashimoto H, Koseki S, Hozumi Y, Kondo S. 1alpha,24-dihydroxyvitamin D3(tacalcitol) is effective against Hailey-Hailey disease both in vivo and in vitro. Br J Dermatol 1998;139:897-901.

  18. Jitsukawa K, Ring J, Weyer U, Kimming W, Radloff H. Topical cyclosporine in chronic benign familiar pemphigus (Hailey-Hailey disease). J Am Acad Dermatol 1992;27:625- 6.

  19. Rabeni E, Cunningham N. Effective treatment of Hailey-Hailey disease with topical tacrolimus. J Am Acad Dermatol 2002;47:797-8.

  20. Ayres S Jr. Hailey-Hailey disease: response to vitamin E therapy. Arch Dermatol 1983;119:450.

  21. Fairris GM, White JE, Leppard BJ, Goodwin PG. Meyhotrexate for intractable benign familial chronic pemphigus. Br J Dermatol 1986;115:640.

  22. Schnizler L. Effet bénefique de la thalidomide dans un cas de pemphigus de Hailey-Hailey: essai sur un an. Ann Dermatol Veneorol 1984;11:285-6.

  23. Hums R. PUVA-therapie bei Pemphigus chronicus benignus familiaris Hailey-Hailey. Dermatol Monatsschr 1984;170:715-8.

  24. Galimberti RL, Kowalczuk AM, Bianchi O, Bonino MV, García-García A. Chronic benign familial pemphigus. Int J Dermatol 1988;27:495-500.

  25. Sire DJ, Johnson BL. Benign familial chronic pemphigus treated with dapsone. Arch Dermatol 1971;103:262-5.

  26. Konstantinovic SV. Clinical aspects and side effects of therapy by oral administration of retinoids in various skin diseases. In: Orfanos CE, Braun-Falco O, Farber EM, Grupper CH, Polano MK, Schuppli R, eds. Retinoids: Advances in Basic Research and Therapy. Berlín: Springer-Verlag, 1981;479-81.

  27. Happle R, Van-de-Kerhof PC, Traupe H. Retinoids in disorders of keratinization: their use in adults. Dermatologica 1987;175(Suppl.1):S107-24.

  28. Berth-Jones J, Smith SG, Graham-Brown RAC. Benign familial chronic pemphigus(Hailey-Hailey disease) responds to cyclosporin. Clin Exp Dermatol 1995;20:70-2.

  29. Ormerod AD, Duncan J, Stankler L. Benign familial pemphigus responsive to cyclosporin, a possible role for cellular immunity in pathogenesis. Br J Dermatol 1991;124:299-305.

  30. Belhaouari L, Chavion JP, Cantala P, Bonafé JL, Costagliola M. Iindications peu communes de dermabrasion. Ann Dermatol Venereol 1983;110:298.

  31. Hamm H, Metze D, Bröcker EB. Hailey-Hailey disease. Erradication by dermabrasion. Arch Dermatol 1994;130: 1143-9.

  32. Kirtschig G, Gieler U, Happle R. Treatment of Hailey-Hailey disease by dermabrasion. J Am Acad Dermatol 1993;28:784-6.

  33. Zachariae H. Dermabrasion of Hailey-Hailey disease and Darier’s disease. J Am Acad Dermatol 1992;27:136.

  34. Barthe L, Fernández AP, Rechert B, Hermans-Le T, Pierard GE, De la Brassinne M, et al. Enfermedad de Hailey-Hailey tratada con dermabrasión. Actas Dermosifiliogr 1997;88:403-6.

  35. Guerin-Surville H, Guerin Surville L, Lelouarn C, Binet O. Traitement chirurgical de la maladie de Hailey-Hailey par greffes chirurgicales. Ann Dermatol Vénéréol 1984;111:699-700.

  36. Menz P, Jackson IT, Connolly S. Surgical control of Hailey-Hailey disease. Br J Plast Surg 1987;40:557-61.

  37. Sánchez E. Interacción del láser de CO2 con la piel humana. Comparación del láser continuo y el superpulsado. Actas Dermosifiliogr 1997;88:257-64.

  38. Touma DJ, Krauss M, Feingold DS, Kaminer MS. Benign familial pemphigus(Hailey-Hailey disease). Treatment with the pulsed carbon dioxide laser. Dermatol Surg 1998;24:1411-4.

  39. Beier C, Kaufmann R. Efficacy of Erbium: YAG laser ablation in Darier disease and Hailey-Hailey disease. Arch Dermatol 1999;135:423-7.

  40. Roos DE, Reid CM. Benign familial pemphigus: Little benefit from superficial radiotherapy. Australas J Dermatol 2002;43: 305-8.

  41. Ruiz-Rodriguez R, Alvarez JG, Jaén P, Acevedo A, Córdoba S. Photodynamic therapy with 5-aminolevulinic acid for recalcitrant familial benign pemphigus (Hailey-Hailey disease). J Am Acad Dermatol 2002;47:740-2.

  42. Lapiere JC, Hirsh A, Gordon KB, Cook B, Montalvo A. Botulinum toxin type A for the treatment of axillary Hailey-Hailey disease. Dermatol Surgery 2000;26:371-4.

  43. Kang N-G, Yoon T-J, Kim T-H. Botulinum toxin type A as an effective adjuvant therapy for Hailey-Hailey disease. Dermatol Surg 2002;28:543.




2020     |     www.medigraphic.com